Pharmaceuticals for Women’s Health Market

Global Pharmaceuticals for Women’s Health Market Size, Share & Trends Analysis Report, By Product (Drugs and Devices), By Application (Contraceptives, Postmenopausal Osteoporosis, and Hormonal Infertility), Forecast (2021-2027)
    Update Available - Forecast 2024-2030   

Published: Jul 2023 | Report Code: OMR2025349 | Category : Pharmaceuticals | Delivery Format: /

The global pharmaceuticals for women’s health market is expected to grow at a significant CAGR during the forecast period (2021-2027). The rising occurrence of polycystic ovary syndrome (PCOS) has aided market growth. The development of medicines for the betterment of women's health is supporting the market growth. There is a variety of drugs, surgical options, and preventative measures available for women for a range of disorders. Changes in food choices, stress, and alcohol intake are the main causes of hormone imbalance in women. The usage of pharmaceutical health care for women's health is steadily increasing.

Owing to the growing elderly population of women, rising cases of chronic diseases such as postmenstrual osteoporosis among women, and increased demand for contraceptives to prevent unintended pregnancies, government initiatives to curb population growth have resulted in an increase in the demand for contraceptives. Women's health is constantly deteriorating as a result of poor behaviours and lifestyles, and they suffer from a variety of disorders. The consumption of poor nutritional products, as well as a number of other key issues, all contribute to the growth of the pharmaceuticals women's health market. The FDA, on the other hand, has applied severe regulatory criteria to the approval of medications for women's disorders, particularly hormone therapies. Nonetheless, in terms of clinical approval approaches such as clinical trial design, interpretation, and analysis, an antibiotic's clinical trial differs from those of other therapeutic medications. For approval, the sponsor must undertake non-inferiority trials in combination with presently registered antibacterial medicines. 

Market Coverage

  • The market number available for – 2020-2027
  • Base year- 2020
  • Forecast period- 2021-2027
  • Segment Covered
  • Regions Covered- Globally

Competitive Landscape: Amgen Inc., Merck & Co., Inc., Pfizer Inc., Bayer AG, Mylan N.V., and Others. 

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominates the market in base year?
  • Which segment and region will project fastest growth in the market?
  • How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Pharmaceuticals for Women’s Health Market Report Segmentation

By Product 

Drugs 

Devices

By Application 

Contraceptives

Postmenopausal Osteoporosis

Hormonal Infertility

Global Pharmaceuticals for Women’s Health Market by Region

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of Europe 

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific 

Rest of the World